CoChat

Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study

Open access
Kokturk, Nurdan, Polatli, Mehmet, Oguzulgen, I Kivilcim, Saleemi, Sarfraz, Al Ghobain, Mohammed, Khan, Javed, Doble, Adam, Tariq, Luqman, Aziz, Fayaz, El Hasnaoui, Abdelkader · 2018 · International Journal of Chronic Obstructive Pulmonary Disease

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

Background: COPD affects millions of people worldwide. Poor treatment adherence contributes to increased symptom severity, morbidity and mortality. This study was designed to investigate adherence to COPD treatment in Turkey and Saudi Arabia. Methods: An observational, cross-sectional study in adult COPD patients in Turkey and Saudi Arabia. Through physician-led interviews, data were collected on sociodemographics and disease history, including the impact of COPD on health status using the COPD Assessment Test (CAT); quality of life, using the EuroQol Five-Dimension questionnaire (EQ-5D); and anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). Treatment adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8). Multivariate logistic regression analysis examined the predictors of non-adherence and the impact of adherence on symptom severity. Results: Four hundred and five COPD patients participated: 199 in Turkey and 206 in Saudi Arabia. Overall, 49.2% reported low adherence (MMAS-8 <6). Of those, 74.7% reported high disease impact (CAT >15) compared to 58.4% reporting medium/high adherence ( p =0.0008). Patients with low adherence reported a lower mean 3-level EQ-5D utility value (0.54±0.35) compared to those with medium/high adherence (0.64±0.30; p <0.0001). Depression with HADS score 8–10 or >10 was associated with lower adherence (OR 2.50 [95% CI: 1.43–4.39] and 2.43 [95% CI: 1.39–4.25], respectively; p =0.0008). Being a high school/college graduate was associated with better adherence compared with no high school (OR 0.57 [95% CI: 0.33–0.98] and 0.38 [95% CI: 0.15–1.00], respectively; p =0.0310). After adjusting for age, gender, and country, a significant association between treatment adherence (MMAS-8 score ≥6) and lower disease impact (CAT ≤15) was observed (OR 0.56 [95% CI: 0.33–0.95]; p =0.0314). Conclusion: Adherence to COPD treatment is poor in Turkey and Saudi Arabia. Non-adherence to treatment is associated with higher disease impact and reduced quality of life. Depression, age, and level of education were independent determinants of adherence. Keywords: COPD, non-adherence, 8-item Morisky Medication Adherence Scale, MMAS-8, EuroQol Five-Dimension questionnaire, EQ-5D, COPD Assessment Test, CAT, Turkey, Saudi Arabia

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/copd.s150411

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Multivariate analysis: predictors of non-adherence to COPD treatment. Notes: Multivariate regression analysis on 355 patients: 170 with low (MMAS-8 <6) adherence to treatment and 185 with medium or high (MMAS-8 ≥6) adherence to treatment (low adherence versus medium/high adherence). *p-value of the Wald Chi-Square test from the logistic regression model. Abbreviations: HADS, Hospital Anxiety and Depression Scale; MMAS-8, 8-item Morisky Medication Adherence Scale.
Figure 1 Multivariate analysis: predictors of non-adherence to COPD treatment. Notes: Multivariate regression analysis on 355 patients: 170 with low (MMAS-8 <6) adherence to treatment and 185 with medium or high (MMAS-8 ≥6) adherence to treatment (low adherence versus medium/high adherence). *p-value of the Wald Chi-Square test from the logistic regression model. Abbreviations: HADS, Hospital Anxiety and Depression Scale; MMAS-8, 8-item Morisky Medication Adherence Scale.CC BY-NC · PubMed Central
Figure 2 Association between treatment adherence and CAT score. Notes: Adjusted analysis (by country, age, and gender) of the association between adherence to treatment and the impact of COPD on health status, measured by the CAT: analysis on 307 patients: 207 with a CAT score of >15 and 100 with a CAT score of ≤15 (>15 versus ≤15). *p-value of the Wald Chi-Square test from the logistic regression model. Abbreviation: CAT, COPD Assessment Test.
Figure 2 Association between treatment adherence and CAT score. Notes: Adjusted analysis (by country, age, and gender) of the association between adherence to treatment and the impact of COPD on health status, measured by the CAT: analysis on 307 patients: 207 with a CAT score of >15 and 100 with a CAT score of ≤15 (>15 versus ≤15). *p-value of the Wald Chi-Square test from the logistic regression model. Abbreviation: CAT, COPD Assessment Test.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. [26]National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health Reports of the Surgeon General The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General Atlanta, GA Centers for Disease Control and Prevention (US) 2014 24455788

Cited by

See all 53

Metadata

Authors
Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A.
Affiliations
  • King Faisal Specialist Hospital & Research Centre (SA)
  • King Fahd Armed Forces Hospital (SA)
Venue
International Journal of Chronic Obstructive Pulmonary Disease
Published
2018-04
Volume
Volume 13
Pages
1377-1388
ISSN
  • 1176-9106 (ISSN-L)
  • 1178-2005
OpenAlex
W2802197918
Cited by
53
References
63
Citations by year
2026: 3 · 2025: 3 · 2024: 11 · 2023: 12 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 4 · 2018: 1
FWCI
5.99
Type
journal article
Language
en
Open access
Locations
  • International Journal of COPD (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
EuroQol Research Foundation
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
chronic obstructive pulmonary disease, medication adherence, predictors of non-adherence, depression, anxiety, quality of life, disease impact, symptom severity, educational attainment, Turkey, Saudi Arabia, Morisky Medication Adherence Scale, COPD Assessment Test, EQ-5D, Hospital Anxiety and Depression Scale, cross-national comparison, patient-reported outcomes
MeSH terms
Adult, Age Factors, Cross-Sectional Studies, Depression, Educational Status, Health Status, Humans, Interviews as Topic, Health Knowledge, Attitudes, Practice, Mental Health, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Severity of Illness Index, Turkey, Multivariate Analysis, Chi-Square Distribution, Logistic Models, Odds Ratio, Treatment Outcome, Pulmonary Disease, Chronic Obstructive, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.